Search

everythinglearnresearchcommunity

for

Search:↓

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

People with polycystic ovary syndrome often have low levels of vitamin D.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Hair loss linked to higher heart disease risk in both men and women.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Patients with alopecia areata might have a lower risk of stroke and possibly heart attack.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

High doses of minoxidil can harm marmoset hearts and kidneys, possibly affecting humans similarly.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

Hair loss may indicate higher heart risk and metabolic issues.

AGA patients have higher heart disease risk.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

Medications for PCOS don't seem to raise heart disease risk.

Research on Hutchinson-Gilford progeria syndrome could help understand normal aging and heart disease.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Testosterone increases heart and blood pressure issues in rats with endotoxemia, and stopping testosterone production can reduce these problems.

Zebrafish with mutations similar to human Cantú Syndrome have heart cells with altered channel properties, making them a good model to study the condition.

High testosterone increases heart disease risk in women with PCOS.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.